Waypoint Bio · 14 hours ago
Part-time Scientist, In Vivo Cancer Biology
New York, NY
Part-time
Onsite
Entry Level
$30/hr - $35/hr
1+ years expWaypoint Bio is a biotech startup building the next generation of cell therapies for solid tumors. They are seeking a highly motivated part-time scientist with hands-on experience in mouse models to support their platform and therapeutic programs.
BiotechnologyComputer VisionMachine Learning
Hiring Manager
David Phizicky
Responsibilities
Help set up and run clinically-relevant mouse models of solid tumors
Perform all steps of •in vivo• mouse studies to assess CAR T efficacy in CDX models (including injections and surgeries for tumor implantation, tumor growth measurements, and harvesting organs for subsequent •ex vivo• analysis)
Use mouse cancer models to apply Waypoint’s pooled CAR-T screening platform •in vivo•
Establish new •in vivo• cancer models and improve the performance and accuracy of existing models
May also perform cell culture & molecular biology experiments
Actively engage in prioritizing key milestones and developing appropriate timelines
Provide conceptual input on •in vivo• experimental design and interpretation in a team setting
Keep detailed scientific records in electronic lab notebook
Qualification
Required
Bachelor's degree in biology, immunology, genetics, cancer biology, or related field
At least 1 year of academic or industry experience working on mouse models in a biology or drug development setting
Technical expertise in mouse injection methods (e.g. IV, SubQ, or IP), subcutaneous tumor implantation and measurements, organ harvesting, animal phenotyping, and adherence to IACUC protocols
Superb organizational abilities and precise scientific record keeping in electronic lab notebooks
Preferred
Experience using luciferase reporters for live-animal imaging
Knowledge of the interplay between the immune system and the tumor microenvironment
Expertise in evaluating cancer therapies in mouse models, especially cell therapies (CAR-T, CAR-NK, TCR-T) or antibody therapies
Company
Waypoint Bio
Optimizing cell therapy with spatial biology
11-50 employees
H1B Sponsorship
Waypoint Bio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2023 (1)
Funding
Current Stage
Early StageTotal Funding
$14.5MKey Investors
Hummingbird Ventures
2024-06-28Seed· $14.5M
Leadership Team
Xinchen Wang
Co-founder and CEO
Company data provided by crunchbase